* Quipt Home Medical Corp QIPT.TO is expected to show a
rise in
quarterly revenue when it reports results on December 18 for
the period ending June 30 2023
* The Wilder Kentucky-based company is expected to report a
56.8% increase in revenue to $62.88 million from $40.09 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Quipt Home Medical Corp
is for
breakeven results per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Quipt Home
Medical Corp is $10.00, above its last closing price of $4.43.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2023 0.00 0.00 -0.03 Missed -1,696
.4
Mar. 31 2023 0.04 0.04 -0.02 Missed -147.1
Dec. 31 2022 0.04 0.05 0.01 Missed -77.8
Sep. 30 2022 0.02 0.02 0.07 Beat 250
Jun. 0.00 0.00 0.00 Met
30 2022
Mar. 31 2022 0.00 0.03 0.14 Beat 366.7
Dec. 31 2021 -0.02 -0.01 -0.06 Missed -799.5
Sep. 30 2021 -0.03 -0.01 -0.04 Missed -220
This summary was machine generated December 15 at 21:11 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)